Published Articles
List of published articles
-
Published online: 2026-10-22
Long-Term Safety and Clinical Outcomes of Motugivatrep (SJP-0132) 0.3% Ophthalmic Suspension in Patients with Dry Eye Disease: An Open-Label, Phase 3 Study
Source: Clinical Ophthalmology DOI: https://doi.org/10.2147/OPTH.S626385
-
Published online: 2026-09-26
Motugivatrep (SJP-0132) 0.3% Ophthalmic Suspension for Dry Eye Disease: A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 3 Trial
Source: Clinical Ophthalmology DOI: https://doi.org/10.2147/OPTH.S615529
-
Published online: 2026-02-28
遠隔転移を有しない去勢抵抗性前立腺癌（nmCRPC） 患者を対象としたダロルタミドの観察研究（DAROL）： 第3 回中間解析における日本人サブグループ解析 Prespecified third interim analysis of the Darolutamide Observational study（DAROL）in patients with nonmetastatic castration-resistant prostate cancer（nmCRPC）： A Japanese subgroup analysis
Source: 泌尿器外科 DOI: https://igakutosho.co.jp/collections/magazine-urinary/products/zh_3902
-
Published online: 2026-01-17
Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 antagonist SJP-0132 in Participants with Dry Eye Disease
Source: American Journal of Ophthalmology DOI: https://www.ajo.com/article/S0002-9394(26)00016-4/abstract
- 1